IL1A and COVID-19: The importance of IL-1 in driving cytokine storm syndromes is seen through the beneficial effects of recombinant IL-1Ra (anakinra) in ameliorating hypercytokinemia in COVID-19 and SJIA complicated with MAS [37, 38].